Synopsis: Four stocks, Ajanta Pharma, Emcure Pharmaceuticals, Capital Small Finance Bank, and BlueStone Jewellery, saw block deals worth over ₹2,000 crore, drawing heavy investor attention. The deals, involving large share transfers, signalled institutional activity and boosted trading volumes across counters
The Shares of Ajanta Pharma, Emcure Pharmaceuticals, Capital Small Finance Bank, and BlueStone Jewellery came under the spotlight on Tuesday after witnessing large block deals collectively valued at more than Rs. 2,000 crore during the block deal window. The sizeable transactions sparked strong investor interest and led to a surge in trading activity across these counters.
Market participants closely tracked the four stocks after the block deals, as such transactions often reflect strategic stake sales by promoters, private equity investors, or large shareholders, and they can also indicate a strong institutional interest. The market watched price movements and trading volumes closely to assess investor sentiment and the potential impact on each company. Here are the details of the block deals in these stocks and how they responded to the transactions
Ajanta Pharma Ltd
Ajanta Pharma Ltd is a specialty pharmaceutical company headquartered in India, engaged in the development, manufacturing, and marketing of branded and generic medicines. The company has a strong presence in therapeutic segments such as ophthalmology, dermatology, cardiology, and pain management. It operates across India and several international markets, particularly in Asia, Africa, and emerging economies.
With a market capitalization of Rs. 37,717.44 crores in the day’s trade, the shares of Ajanta Pharma Ltd rose upto 3.8 percent, making a high of Rs. 3,085.00 per share compared to its previous closing price of Rs. 2,970.00 per share.
In a significant block deal, about 34.5 lakh shares of Ajanta Pharma were traded, with the transaction valued at nearly Rs. 1,024 crore. The deal was executed at a price of Rs. 2,968 per share, indicating substantial investor activity and drawing market attention to the pharmaceutical company’s stock.
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd is a leading Indian pharmaceutical company focused on research, development, manufacturing, and global marketing of a wide range of medicines. Its portfolio covers areas such as women’s health, cardiology, oncology, HIV treatment, and biologics. The company exports products to numerous countries and is recognised for its innovation-driven approach and strong domestic presence.
With a market capitalization of Rs. 33,109.82 crores in the day’s trade, the shares of Emcure Pharmaceuticals Ltd rose upto 4.3 percent, making a high of Rs. 1,794.00 per share compared to its previous closing price of Rs. 1,719.55 per share.
In a notable block deal, around 36 lakh shares of Emcure Pharmaceuticals changed hands, with the transaction valued at approximately Rs. 612 crore. The shares were traded at an average price of Rs. 1,700 each, representing about 1.9 percent of the company’s total equity base.
Capital Small Finance Bank Ltd
Capital Small Finance Bank Ltd is India’s first small finance bank, primarily serving retail and agricultural customers. Headquartered in Punjab, the bank offers savings accounts, fixed deposits, loans, and digital banking services. It focuses on financial inclusion by catering to underserved rural and semi-urban regions while maintaining a strong presence in northern India.
With a market capitalization of Rs. 1,241.19 crores in the day’s trade, the shares of Capital Small Finance Bank Ltd rose upto 1.87 percent, making a high of Rs. 274.40 per share compared to its previous closing price of Rs. 269.35 per share.
In a block deal, approximately 13.62 lakh shares of Capital Small Finance Bank changed hands at Rs. 270 per share, with the transaction valued at nearly Rs. 37 crore. The deal represents around 3 percent of the bank’s outstanding equity, indicating notable investor participation.
Bluestone Jewellery & Lifestyle Ltd
Bluestone Jewellery & Lifestyle Ltd is a prominent omnichannel jewellery retailer in India, known for its extensive collection of gold, diamond, platinum, and gemstone jewellery. The company combines online convenience with physical retail stores, offering customized designs and modern shopping experiences. Its technology-driven business model has helped it establish a strong brand among contemporary jewellery buyers.
With a market capitalization of Rs. 8,046.94 crores in the day’s trade, the shares of Bluestone Jewellery & Lifestyle Ltd declined upto 6.4 percent, making a low of Rs. 512.80 per share compared to its previous closing price of Rs. 548.30 per share.
In a major block deal, around 67.6 lakh shares of BlueStone Jewellery changed hands, marking the largest transaction among the four companies. The shares represented about 4.4 percent of the company’s equity capital and were traded at an average price of Rs. 527 per share, valuing the deal at nearly Rs. 356 crore.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
